Shandong Weigao completes share buyback, increases treasury holdings

On October 21, 2025, Shandong Weigao Group Medical Polymer Company Limited repurchased 177,200 ordinary H shares on the Exchange. The shares were bought at a volume-weighted average price of HK$5.609, with prices ranging from HK$5.62 to HK$5.59. The total aggregate price paid for this buyback amounted to HK$993,920.

Following this transaction, the company's issued shares (excluding treasury shares) decreased by 177,200, representing a 0.0039% reduction from the previous balance. The closing balance of issued shares (excluding treasury shares) is now 4,500,063,524. Consequently, the number of treasury shares held increased by 177,200, bringing the new total to 22,268,800.

The repurchase was made under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares. To date, 15,620,400 shares have been repurchased on the Exchange under this mandate, representing 3.4592% of the issued shares (excluding treasury shares) as of the resolution date. The company has a moratorium period for new share issues or treasury share transfers until November 20, 2025.